Gene editing to treat Rett syndrome
Project 4: Therapeutic Gene Editing for Rett Syndrome
This study is exploring new gene editing treatments for Rett syndrome, a condition that mainly affects girls and causes challenges with movement and communication, to see if we can fix the genetic changes that lead to these symptoms and improve their quality of life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Jackson Laboratory NIH-funded |
| Lab location | 1 site (Bar Harbor, United States) |
| Project ID | NIH-11089360 on NIH RePORTER |
What this research studies
This research focuses on developing therapeutic gene editing techniques to address Rett syndrome, a neurodevelopmental disorder primarily affecting females due to mutations in the MECP2 gene. The project aims to utilize advanced gene editing methods to correct specific mutations that lead to the symptoms of Rett syndrome, such as loss of motor skills and communication abilities. By leveraging insights from animal models, the research seeks to demonstrate the potential reversibility of neurological deficits associated with this condition. Patients may be involved in trials that assess the safety and efficacy of these innovative treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are females diagnosed with Rett syndrome, particularly those with specific mutations in the MECP2 gene.
Not a fit: Patients with Rett syndrome who do not have the targeted MECP2 mutations or those with other unrelated neurodevelopmental disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for patients with Rett syndrome by potentially reversing neurological deficits.
How similar studies have performed: Previous studies using gene editing in animal models have shown promising results in reversing symptoms of Rett syndrome, indicating a potential pathway for successful treatment.
Where this research is happening
Bar Harbor, United States
- Jackson Laboratory — Bar Harbor, United States (Active)
Researchers
- Principal investigator: Lutz, Cathleen M — Jackson Laboratory
- Study coordinator: Lutz, Cathleen M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.